Takeda Pharmaceutical Net Income 2007-2019 | TAK

Takeda Pharmaceutical annual/quarterly net income history and growth rate from 2007 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Takeda Pharmaceutical net income for the quarter ending December 31, 2019 was $-0.296B, a 141.18% decline year-over-year.
  • Takeda Pharmaceutical net income for the twelve months ending December 31, 2019 was $0.352B, a 88.81% decline year-over-year.
  • Takeda Pharmaceutical annual net income for 2020 was $0.407B, a 58.56% decline from 2019.
  • Takeda Pharmaceutical annual net income for 2019 was $0.982B, a 41.61% decline from 2018.
  • Takeda Pharmaceutical annual net income for 2018 was $1.682B, a 57.35% increase from 2017.
Takeda Pharmaceutical Annual Net Income
(Millions of US $)
2020 $407
2019 $982
2018 $1,682
2017 $1,069
2016 $665
2015 $-1,327
2014 $1,067
2013 $1,588
2012 $1,577
2011 $2,986
2010 $3,202
2009 $2,392
2008 $3,555
2007 $2,846
2006 $2,677
Takeda Pharmaceutical Quarterly Net Income
(Millions of US $)
2019-12-31 $-296
2019-09-30 $501
2019-06-30 $-188
2018-12-31 $336
2018-06-30 $720
2017-06-30 $1,303
2016-06-30 $926
2015-06-30 $202
2015-03-31 $-1,892
2014-12-31 $156
2014-09-30 $260
2014-06-30 $326
2014-03-31 $-43
2013-12-31 $457
2013-09-30 $360
2013-06-30 $296
2013-03-31 $462
2012-12-31 $236
2012-09-30 $409
2012-06-30 $1,119
2012-03-31 $-460
2011-12-31 $322
2011-09-30 $775
2011-03-31 $394
2010-03-31 $426
2009-09-30 $-1
2009-03-31 $705
2008-03-31 $-922
2007-03-31 $583
2006-03-31 $275
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $58.011B $30.200B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.739B 37.88
Astellas Pharma (ALPMY) Japan $32.072B 16.02
Eisai (ESALY) Japan $23.340B 43.48
UCB SA (UCBJF) Belgium $19.723B 0.00
Merck (MKGAF) Germany $14.934B 19.58
Grifols, S.A (GRFS) Spain $13.579B 16.88
Catalent (CTLT) United States $11.913B 46.05
Neurocrine Biosciences (NBIX) United States $11.154B 51.55
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $7.782B 41.38
Orion OYJ (ORINY) Finland $7.289B 32.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.270B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.744B 10.80
IPSEN SA ADR (IPSEY) France $6.676B 0.00
United Therapeutics (UTHR) United States $5.388B 10.21
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Hypermarcas (HYPMY) Brazil $4.192B 12.75
Evotec AG (EVTCY) Germany $4.119B 66.40
Nektar Therapeutics (NKTR) United States $4.112B 0.00
ChemoCentryx (CCXI) United States $3.711B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.303B 360.56
PTC Therapeutics (PTCT) United States $3.008B 0.00
FibroGen (FGEN) United States $2.913B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.603B 10.70
Cronos Group (CRON) Canada $2.334B 66.90
Pacira BioSciences (PCRX) United States $1.976B 40.45
Sage Therapeutics (SAGE) United States $1.826B 0.00
USANA Health Sciences (USNA) United States $1.794B 18.40
Xencor (XNCR) United States $1.702B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.699B 0.00
Heron Therapeutics (HRTX) United States $1.671B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.659B 0.00
Zogenix (ZGNX) United States $1.629B 0.00
Corcept Therapeutics (CORT) United States $1.618B 16.05
Akebia Therapeutics (AKBA) United States $1.587B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.560B 11.94
Portola Pharmaceuticals (PTLA) United States $1.406B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 15.06
Karyopharm Therapeutics (KPTI) United States $1.302B 0.00
Tilray (TLRY) Canada $1.260B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.200B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.002B 44.71
Translate Bio (TBIO) United States $0.984B 0.00
Endo (ENDP) Ireland $0.914B 1.42
ImmunoGen (IMGN) United States $0.801B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.769B 0.00
Aerie Pharmaceuticals (AERI) United States $0.684B 0.00
Molecular Templates (MTEM) United States $0.684B 0.00
Collegium Pharmaceutical (COLL) United States $0.681B 0.00
Indivior (INVVY) United States $0.640B 7.94
Ardelyx (ARDX) United States $0.616B 0.00
Trillium Therapeutics (TRIL) Canada $0.613B 0.00
Radius Health (RDUS) United States $0.568B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.508B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.499B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.485B 0.00
Flexion Therapeutics (FLXN) United States $0.458B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.448B 10.82
DURECT (DRRX) United States $0.445B 0.00
Organogenesis Holdings (ORGO) United States $0.435B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.433B 16.91
Harpoon Therapeutics (HARP) United States $0.433B 0.00
MEI Pharma (MEIP) United States $0.410B 0.00
Ocular Therapeutix (OCUL) United States $0.377B 0.00
Calithera Biosciences (CALA) United States $0.368B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.346B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.319B 0.00
TherapeuticsMD (TXMD) United States $0.304B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.302B 0.00
Lannett Co Inc (LCI) United States $0.299B 6.55
Oasmia Pharmaceutical AB (OASMY) Sweden $0.279B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
CASI Pharmaceuticals (CASI) United States $0.264B 0.00
Redhill Biopharma (RDHL) Israel $0.244B 0.00
OptiNose (OPTN) United States $0.243B 0.00
Rafael Holdings (RFL) United States $0.236B 0.00
KalVista Pharmaceuticals (KALV) United States $0.209B 0.00
PROFOUND MEDICL (PROF) Canada $0.202B 0.00
Jounce Therapeutics (JNCE) United States $0.196B 4.68
VAXART, INC (VXRT) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 25.39
Taiwan Liposome (TLC) Taiwan $0.185B 0.00
Xeris Pharmaceuticals (XERS) United States $0.176B 0.00
IMV INC (IMV) Canada $0.176B 0.00
Aquestive Therapeutics (AQST) United States $0.173B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.137B 0.00
Altimmune (ALT) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
Recro Pharma (REPH) United States $0.110B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.091B 0.00
Otonomy (OTIC) United States $0.091B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.081B 0.00
CTI BioPharma (CTIC) United States $0.081B 0.00
CV Sciences (CVSI) United States $0.078B 0.00
Hemispherx BioPharma (AIM) United States $0.078B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.076B 0.00
Onconova Therapeutics (ONTX) United States $0.076B 0.00
Heat Biologics (HTBX) United States $0.075B 0.00
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
MediWound (MDWD) Israel $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Biomerica (BMRA) United States $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.36
Opiant Pharmaceuticals (OPNT) United States $0.050B 105.82
Natural Alternatives (NAII) United States $0.049B 0.00
IsoRay (ISR) United States $0.048B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.045B 0.00
GTx (ONCT) United States $0.045B 0.00
Lipocine (LPCN) United States $0.043B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 7.37
Neos Therapeutics (NEOS) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Novan (NOVN) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00